Xponance Inc. Sells 6,382 Shares of Ventas, Inc. $VTR

Xponance Inc. cut its holdings in shares of Ventas, Inc. (NYSE:VTR) by 8.3% during the 3rd quarter, Holdings Channel.com reports. The firm owned 70,183 shares of the real estate investment trust’s stock after selling 6,382 shares during the quarter. Xponance Inc.’s holdings in Ventas were worth $4,912,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. NewEdge Advisors LLC lifted its stake in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after buying an additional 7,097 shares in the last quarter. Empowered Funds LLC raised its holdings in Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 536 shares during the period. Woodline Partners LP lifted its position in shares of Ventas by 46.8% during the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after acquiring an additional 11,739 shares in the last quarter. Focus Partners Wealth lifted its position in shares of Ventas by 130.4% during the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after acquiring an additional 12,233 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of Ventas by 19.0% in the second quarter. Envestnet Asset Management Inc. now owns 372,054 shares of the real estate investment trust’s stock worth $23,489,000 after acquiring an additional 59,522 shares during the period. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Analyst Upgrades and Downgrades

VTR has been the topic of a number of analyst reports. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Scotiabank lifted their target price on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. UBS Group reiterated a “neutral” rating and set a $85.00 price target on shares of Ventas in a research report on Monday, February 9th. Citigroup increased their price target on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Finally, Wells Fargo & Company boosted their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Ventas has a consensus rating of “Moderate Buy” and an average target price of $86.87.

Insiders Place Their Bets

In other news, CEO Debra A. Cafaro sold 10,322 shares of the business’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total transaction of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. The trade was a 0.92% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This represents a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 86,106 shares of company stock worth $6,931,397 over the last three months. Company insiders own 1.00% of the company’s stock.

Ventas Price Performance

Shares of NYSE VTR opened at $86.38 on Monday. The stock’s 50-day simple moving average is $80.00 and its two-hundred day simple moving average is $75.17. Ventas, Inc. has a twelve month low of $60.15 and a twelve month high of $87.87. The firm has a market capitalization of $41.03 billion, a P/E ratio of 159.96, a P/E/G ratio of 2.11 and a beta of 0.73. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm posted $0.81 EPS. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is presently 355.56%.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.